RCAN1 and Alzheimer disease: To elucidate the role of DSCR1 in modulating APP-induced phenotypes, we used Drosophila as a model system, which has been used successfully to investigate various human neurodegenerative diseases including AD, Parkinson's, and polyglutamine-repeat diseases [18]–[27].